Abstract
Abstract The 2022 American Heart Association /American College of Cardiology /Heart Failure Society of America Guideline, for the Management of Heart Failure, aimed to provide an update and consolidate the earlier versions, into a new document. Areas of focus in the 2022 heart failure (HF) guidelines are the prevention of HF and the new treatment strategies in HF using contemporary approaches to care. Influenza vaccination, a key nonpharmacologic intervention tested in a large cohort of HF patients including Nigerians, could significantly reduce clinical outcomes. This commentary aimed to clarify the relevance of this international standard practice guideline on HF, to the practice in Nigeria, and highlight the existing peculiarities. It is hoped that this commentary would serve as a prelude to a future Nigerian guideline for the management of HF.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
